Mezzasalma Advisors, LLC Moderna, Inc. Transaction History

Mezzasalma Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$126.46 - $235.05 $2.84 Million - $5.27 Million	-22,432 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$225.82 - $368.51 $2,709 - $4,422	12 Added 0.05%	22,432 $5.7 Million
Q3 2021 Oct 19, 2021	BUY	$221.9 - $484.47 $190,834 - $416,644	860 Added 3.99%	22,420 $8.63 Million
Q2 2021 Jul 14, 2021	BUY	$129.91 - $234.98 $2,598 - $4,699	20 Added 0.09%	21,560 $5.07 Million
Q1 2021 Jun 01, 2021	SELL	$109.18 - $185.98 $27,295 - $46,495	-250 Reduced 1.15%	21,540 $2.82 Million
Q4 2020 Jun 01, 2021	BUY	$65.74 - $169.86 $1.43 Million - $3.7 Million	21,790 New	21,790 $2.28 Million

1,048

242M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $21.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mezzasalma Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mezzasalma Advisors, LLC with notifications on news.